Uncivil engineers: Chlamydia, Salmonella and Shigella alter cytoskeleton architecture to invade epithelial cells

Future Microbiology

Volumn 5, Issue 8, 2010, Pages 1219-1232

  Dunn, Joe Dan ^a   Valdivia, Raphael H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Abl; actin; Chlamydia; cytoskeleton; effector; invasion; Rho GTPase; Salmonella; Shigella; type III secretion

Indexed keywords

ACTIN; BACTERIAL PROTEIN; PROTEIN TYROSINE KINASE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

BACTERIAL MEMBRANE; BACTERIUM ADHERENCE; CELL INVASION; CELL MEMBRANE; CHLAMYDIA; CHLAMYDIA TRACHOMATIS; CYTOARCHITECTURE; CYTOSKELETON; ENZYME ACTIVATION; EPITHELIUM CELL; HOST PATHOGEN INTERACTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SALMONELLA; SHIGELLA; SIGNAL TRANSDUCTION;

CHLAMYDIA TRACHOMATIS; CYTOSKELETON; ENDOCYTOSIS; EPITHELIAL CELLS; HUMANS; MODELS, BIOLOGICAL; SALMONELLA; SHIGELLA; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDIA TRACHOMATIS; SALMONELLA; SHIGELLA;

EID: 77955973992     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.10.77     Document Type: Review

References (134)

1. Brunham RC, Rey-Ladino J: Immunology of Chlamydia infection: Implications for a Chlamydia trachomatis vaccine. Nat. Rev. Immunol. 5(2), 149-161 (2005).
2. Roan NR, Starnbach MN: Immune-mediated control of Chlamydia infection. Cell Microbiol. 10(1), 9-19 (2008).
3. Wright HR, Turner A, Taylor HR: Trachoma. Lancet 371(9628), 1945-1954 (2008).
4. Campbell LA, Kuo C-C: Chlamydia pneumoniae -an infectious risk factor for atherosclerosis? Nat. Rev. Microbiol. 2(1), 23-32 (2004).
5. Abdelrahman YM, Belland RJ: The chlamydial developmental cycle. FEMS Microbiol. Rev. 29(5), 949-959 (2005).
6. Fields KA, Hackstadt T: The chlamydial inclusion: escape from the endocytic pathway. Annu. Rev. Cell Dev. Biol. 18, 221-245 (2002).
7. Hybiske K, Stephens RS: Mechanisms of host rel I exit by the i ntracel lnlar bacterium Chlamydia. Proc. Natl Acad. Sci. USA 104(27), 11430-11435 (2007).
8. Cossart P, Sansonetti PJ: Bacterial invasion: The paradigms of enteroinvasive pathogens. Science 304(5668), 242-248 (2004).
9. Mostowy S, Cossart P: Cytoskeleton rearrangements during listeria infection: clathrin and septins as new players in the game. CellMotil. Cytoskeleton 66(10), 816-823 (2009).
10. Bonazzi M, Lecuit M, Cossart P: Listeria monocytogenes internalin and e-cadherin: from structure to pathogenesis. Cell Microbiol. (2009) DOI: 10.1111/j.1462-5822.2009.01293.x (Epub ahead of print).
11. Ly KT, Casanova JE: Mechanisms of Salmonella entry into host cells. Cell Microbiol. 9(9), 2103-2111 (2007).
12. Horn M, Collingro A, Schmitz-Esser S et al.: Illuminating the evolutionary history of chlamydiae. Science 304(5671), 728-730 (2004).
13. Fields KA, Mead DJ, Dooley CA, Hackstadt T: Chlamydia trachomatis type III secretion: evidence for a functional apparatus during early-cycle development. Mol. Microbiol. 48(3), 671-683 (2003).
14. Subtil A, Parsot C, Dautry-Varsat A: Secretion of predicted INC proteins of Chlamydia pneumoniae by a heterologous type III machinery. Mol. Microbiol. 39(3), 792-800 (2001).
15. Beeckman DSA, Vanrompay DCG: Bacterial secretion systems with an emphasis on the chlamydial type III secretion system. Curr. Issues Mol. Biol. 12(1), 17-42 (2009).
16. Enninga J, Rosenshine I: Imaging the assembly, structure and activity of type III secretion systems. Cell Microbiol. 11(10), 1462-1470 (2009).
17. Humphries AD, Townsend SM, Kingsley RA, Nicholson TL, Tsolis RM, Baumler AJ: Role of fimbriae as antigens and intestinal colonization factors of Salmonella serovars. FEMS Microbiol. Lett. 201(2), 121-125 (2001).
18. Townsend SM, Kramer NE, Edwards R et al.: Salmonella enterica serovar Typhi possesses a unique repertoire of fimbrial gene sequences. Infect. Immun. 69(5), 2894-2901 (2001).
19. Lambert MA, Smith SGJ: The PAGN protein of Salmonella enterica serovar Typhimurium is an adhesin and invasin. BMC Microbiol. 8, 142 (2008).
20. Ibarra JA, Steele-Mortimer O: Salmonella -the ultimate insider. Salmonella virulence factors that modulate intracellular survival. Cell Microbiol. 11(11), 1579-1586 (2009).
21. Snellings NJ, Tall BD, Venkatesan MM: Characterization of Shigella type 1 fimbriae: expression, fima sequence, and phase variation. Infect. Immun. 65(6), 2462-2467 (1997).
22. Elwell CA, Ceesay A, Kim JH, Kalman D, Engel JN: RNA interference screen identifies Abl kinase and PDGFR signaling in Chlamydia trachomatis entry. PLoS Pathog. 4(3), e1000021 (2008).
23. Zhang JP, Stephens RS: Mechanism of C. trachomatis attachment to eukaryotic host cells. Cell 69(5), 861-869 (1992).
24. Chen JC, Zhang JP, Stephens RS: Structural requirements of heparin binding to Chlamydia trachomatis. J. Biol. Chem. 271(19), 11134-11140 (1996).
25. Chen JC, Stephens RS: Trachoma and lgv biovars of Chlamydia trachomatis share the same glycosaminoglycan-dependent mechanism for infection of eukaryotic cells. Mol. Microbiol. 11(3), 501-507 (1994).
26. Yabushita H, Noguchi Y, Habuchi H et al.: Effects of chemically modified heparin on Chlamydia trachomatis serovar l2 infection of eukaryotic cells in culture. Glycobiology 12(5), 345-351 (2002).
27. Taraktchoglou M, Pacey AA, Turnbull JE, Eley A: Infectivity of Chlamydia trachomatis serovar lgV but not E is dependent on host cell heparan sulfate. Infect. Immun. 69(2), 968-976 (2001).
28. Davis CH, Wyrick PB: Differences in the association of Chlamydia trachomatis serovar e and serovar L2 with epithelial cells in vitro may reflect biological differences in vivo. Infect. Immun. 65(7), 2914-2924 (1997).
29. Su H, Raymond L, Rockey DD, Fischer E, Hackstadt T, Caldwell HD: A recombinant Chlamydia trachomatis major outer membrane protein binds to heparan sulfate receptors on epithelial cells. Proc. Natl Acad. Sci. USA 93(20), 11143-11148 (1996).
30. Rasmussen-Lathrop SJ, Koshiyama K, Phillips N, Stephens RS: Chlamydia-dependent biosynthesis of a heparan sulphate-like compound in eukaryotic cells. CellMicrobiol. 2(2), 137-144 (2000).
31. Turano C, Coppari S, Altieri F, Ferraro A: Proteins of the PDI family: unpredicted non-ER locations and functions. J. Cell Physiol. 193(2), 154-163 (2002).
32. Abromaitis S, Stephens RS: Attachment and entry of Chlamydia have distinct requirements for host protein disulfide isomerase. PLoS Pathog. 5(4), e1000357 (2009).
33. Conant CG, Stephens RS: Chlamydia attachment to mammalian cells requires protein disulfide isomerase. Cell Microbiol. 9(1), 222-232 (2007).
34. Fudyk T, Olinger L, Stephens RS: Selection of mutant cell lines resistant to infection by Chlamydia spp [corrected]. Infect. Immun. 70(11), 6444-6447 (2002).
35. Davis CH, Raulston JE, Wyrick PB: Protein disulfide isomerase, a component of the estrogen receptor complex, is associated with Chlamydia trachomatis serovar e attached to human endometrial epithelial cells. Infect. Immun. 70(7), 3413-3418 (2002).
36. Ryser HJ, Levy EM, Mandel R, Disciullo GJ: Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction. Proc. Natl Acad. Sci. USA 91(10), 4559-4563 (1994).
37. Mandel R, Ryser HJ, Ghani F, Wu M, Peak D: Inhibition of a reductive function of the plasma membrane by bacitracin and antibodies against protein disulfide-isomerase. Proc. Natl Acad. Sci. USA 90(9), 4112-4116 (1993).
38. Carabeo RA, Hackstadt T: Isolation and characterization of a mutant chinese hamster ovary cell line that is resistant to Chlamydia trachomatis infection at a novel step in the attachment process. Infect. Immun. 69(9), 5899-5904 (2001).
39. Epler CR, Dickenson NE, Olive AJ, Picking WL, Picking WD: Liposomes recruit IpaC to the Shigella flexneri type III secretion apparatus needle as a final step in secretion induction. Infect. Immun. 77(7), 2754-2761 (2009).
40. Hayward RD, Cain RJ, Mcghie EJ, Phillips N, Garner MJ, Koronakis V: Cholesterol binding by the bacterial type III translocon is essential for virulence effector delivery into mammalian cells. Mol. Microbiol. 56(3), 590-603 (2005).
41. Lafont F, Van Der Goot FG: Bacterial invasion via lipid rafts. Cell Microbiol. 7(5), 613-620 (2005).
42. Van Der Goot FG, Tran Van Nhieu G, Allaoui A, Sansonetti P, Lafont F: Rafts can trigger contact-mediated secretion of bacterial effectors via a lipid-based mechanism. J. Biol. Chem. 279(46), 47792-47798 (2004).
43. Kenjale R, Wilson J, Zenk SF et al.: The needle component of the type III secreton of Shigella regulates the activity of the secretion apparatus. J. Biol. Chem. 280(52), 42929-42937 (2005).
44. Espina M, Olive AJ, Kenjale R et al.: IpaD localizes to the tip of the type III secretion system needle of Shigella flexneri. Infect. Immun. 74(8), 4391-4400 (2006).
45. Sani M, Botteaux A, Parsot C, Sansonetti P, Boekema EJ, Allaoui A: IpaD is localized at the tip of the Shigella flexneri type III secretion apparatus. Biochim. Biophys. Acta 1770(2), 307-311 (2007).
46. Stensrud KF, Adam PR, La Mar CD et al.: Deoxycholate interacts with IpaD of Shigella flexneri in inducing the recruitment of IpaB to the type III secretion apparatus needle tip. J. Biol. Chem. 283(27), 18646-18654 (2008).
47. Roehrich AD, Martinez-Argudo I, Johnson S, Blocker AJ, Veenendaal AKJ: The extreme c-terminus of Shigella IpaB is required for regulation of t3ss secretion, needle-tip composition and binding. Infect. Immun. 78(4), 1682-1691 (2010).
48. Lara-Tejero M, Galan JE: Salmonella enterica serovar Typhimurium pathogenicity island 1-encoded type III secretion system translocases mediate intimate attachment to nonphagocytic cells. Infect. Immun. 77(7), 2635-2642 (2009).
49. Fields KA, Fischer ER, Mead DJ, Hackstadt T: Analysis of putative Chlamydia trachomatis chaperones Scc2 and Scc3 and their use in the identification of type III secretion substrates. J. Bacteriol. 187(18), 6466-6478 (2005).
50. Markham AP, Jaafar ZA, Kemege KE, Middaugh CR, Hefty PS: Biophysical characterization of Chlamydia trachomatis ct584 supports its potential role as a type III secretion needle tip protein. Biochemistry 48(43), 10353-10361 (2009).
51. Spaeth KE, Chen Y-S, Valdivia RH: The Chlamydia type III secretion system c-ring engages a chaperone-effector protein complex. PLoSPathog. 5(9), e1000579 (2009).
52. Jamison WP, Hackstadt T: Induction of type III secretion by cell-free Chlamydia trachomatis elementary bodies. Microb. Pathog. 45(5-6), 435-440 (2008).
53. Ridley AJ: Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol. 16(10), 522-529 (2006).
54. Weber SS, Ragaz C, Hilbi H: Pathogen trafficking pathways and host phosphoinositide metabolism. Mol. Microbiol. 71(6), 1341-1352 (2009).
55. Di Paolo G, De Camilli P: Phosphoinositides in cell regulation and membrane dynamics. Nature 443(7112), 651-657 (2006).
56. Huveneers S, Danen EHJ: Adhesion signaling -crosstalk between integrins, Src and Rho. J. Cell Sci. 122(Pt 8), 1059-1069 (2009).
57. Zandy NL, Pendergast AM: Abl tyrosine kinases modulate cadherin-dependent adhesion upstream and downstream of rho family GTPases. Cell Cycle 7(4), 444-448 (2008).
58. Veracini L, Franco M, Boureux A, Simon V, Roche S, Benistant C: Two functionally distinct pools of Src kinases for PDGF receptor signalling. Biochem. Soc. Trans. 33(Pt 6), 1313-1315 (2005).
59. Patel JC, Galan JE: Differential activation and function of rho GTPases during Salmonella-host cell interactions. J. Cell Biol. 175(3), 453-463 (2006).
60. Zhou D, Chen LM, Hernandez L, Shears SB, Galan JE: A Salmonella inositol polyphosphatase acts in conjunction with other bacterial effectors to promote host cell actin cytoskeleton rearrangements and bacterial internalization. Mol. Microbiol. 39(2), 248-259 (2001).
61. Hardt WD, Chen LM, Schuebel KE, Bustelo XR, Galan JE: S. Typhimurium encodes an activator of rho GTPases that induces membrane ruffling and nuclear responses in host cells. Cell 93(5), 815-826 (1998).
62. Buchwald G, Friebel A, Galan JE, Hardt W-D, Wittinghofer A, Scheffzek K: Structural basis for the reversible activation of a rho protein by the bacterial toxin sope. EMBO J. 21(13), 3286-3295 (2002).
63. Qi H, Fournier A, Grenier J, Fillion C, Labrie Y, Labrie C: Isolation of the novel human guanine nucleotide exchange factor Src homology 3 domain-containing guanine nucleotide exchange factor (SGEF) and of c-terminal SGEF, an N-terminally truncated form of SGEF, the expression of which is regulated by androgen in prostate cancer cells. Endocrinology 144(5), 1742-1752 (2003).
64. Brown MD, Bry L, Li Z, Sacks DB: IQGAP1 regulates Salmonella invasion through interactions with actin, Rac1, and Cdc42. J. Biol. Chem. 282(41), 30265-30272 (2007).
65. Hart MJ, Callow MG, Souza B, Polakis P: Iqgap1, a calmodulin-binding protein with a rasgap-related domain, is a potential effector for cdc42hs. EMBO J. 15(12), 2997-3005 (1996).
66. +/calmodulin and cdc42 signaling. J. Biol. Chem. 274(1), 464-470 (1999).
67. Fu Y, Galan JE: A Salmonella protein antagonizes rac-1 and cdc42 to mediate host-cell recovery after bacterial invasion. Nature 401(6750), 293-297 (1999).
68. Van Engelenburg SB, Palmer AE: Quantification of real-time Salmonella effector type III secretion kinetics reveals differential secretion rates for sope2 and SPTP. Chem. Biol. 15(6), 619-628 (2008).
69. Kubori T, Galan JE: Temporal regulation of Salmonella virulence effector function by proteasome-dependent protein degradation. Cell 115(3), 333-342 (2003).
70. Shibata T, Takeshima F, Chen F, Alt FW, Snapper SB: Cdc42 facilitates invasion but not the actin-based motility of Shigella. Curr. Biol. 12(4), 341-345 (2002).
71. Mounier J, Laurent V, Hall A et al.: Rho family GTPases control entry of Shigella flexneri into epithelial cells but not intracellular motility. J. Cell Sci. 112 (Pt 13), 2069-2080 (1999).
72. Tran Van Nhieu G, Caron E, Hall A, Sansonetti PJ: IpaC induces actin polymerization and filopodia formation during Shigella entry into epithelial cells. EMBO J. 18(12), 3249-3262 (1999).
73. Watarai M, Kamata Y, Kozaki S, Sasakawa C: Rho, a small GTP-binding protein, is essential for Shigella invasion of epithelial cells. J. Exp. Med. 185(2), 281-292 (1997).
74. Adam T, Giry M, Boquet P, Sansonetti P: Rho-dependent membrane folding causes Shigella entry into epithelial cells. EMBO J. 15(13), 3315-3321 (1996).
75. Huang Z, Sutton SE, Wallenfang AJ et al.: Structural insights into host GTPase isoform selection by a family of bacterial GEF mimics. Nat. Struct. Mol. Biol. 16(8), 853-860 (2009).
76. Handa Y, Suzuki M, Ohya K et al.: Shigella ipgb1 promotes bacterial entry through the elmo-dock180 machinery. Nat. Cell Biol. 9(1), 121-128 (2007).
77. Alto NM, Shao F, Lazar CS et al.: Identification of a bacterial type III effector family with G protein mimicry functions. Cell 124(1), 133-145 (2006).
78. Ohya K, Handa Y, Ogawa M, Suzuki M, Sasakawa C: Ipgb1 is a novel Shigella effector protein involved in bacterial invasion of host cells. Its activity to promote membrane ruffling via rac1 and cdc42 activation. J. Biol. Chem. 280(25), 24022-24034 (2005).
79. Terry CM, Picking WL, Birket SE et al.: The c-terminus of IpaC is required for effector activities related to Shigella invasion of host cells. Microb. Pathog. 45(4), 282-289 (2008).
80. Carabeo RA, Grieshaber SS, Hasenkrug A, Dooley C, Hackstadt T: Requirement for the rac GTPase in Chlamydia trachomatis invasion of non-phagocytic cells. Traffic 5(6), 418-425 (2004).
81. Subtil A, Wyplosz B, Balana ME, Dautry-Varsat A: Analysis of Chlamydia caviae entry sites and involvement of cdc42 and rac activity. J. Cell Sci. 117(Pt 17), 3923-3933 (2004).
82. Derre I, Pypaert M, Dautry-Varsat A, Agaisse H: RNAi screen in drosophila cells reveals the involvement of the tom complex in Chlamydia infection. PLoS Pathog. 3(10), 1446-1458 (2007).
83. Carabeo RA, Dooley CA, Grieshaber SS, Hackstadt T: Rac interacts with abi-1 and wave2 to promote an arp2/3-dependent actin recruitment during chlamydial invasion. Cell Microbiol. 9(9), 2278-2288 (2007).
84. Lane BJ, Mutchler C, Al Khodor S, Grieshaber SS, Carabeo RA: Chlamydial entry involves tarp binding of guanine nucleotide exchange factors. PLoS Pathog. 4(3), e1000014 (2008).
85. Clifton DR, Fields KA, Grieshaber SS et al.: A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc. Natl Acad. Sci. USA 101(27), 10166-10171 (2004).
86. Clifton DR, Dooley CA, Grieshaber SS, Carabeo RA, Fields KA, Hackstadt T: Tyrosine phosphorylation of the chlamydial effector protein tarp is species specific and not required for recruitment of actin. Infect. Immun. 73(7), 3860-3868 (2005).
87. Jewett TJ, Dooley CA, Mead DJ, Hackstadt T: Chlamydia trachomatis tarp is phosphorylated by Src family tyrosine kinases. Biochem. Biophys. Res. Commun. 371(2), 339-344 (2008).
88. Mehlitz A, Banhart S, Hess S, Selbach M, Meyer TF: Complex kinase requirements for Chlamydia trachomatis tarp phosphorylation. FEMS Microbiol. Lett. 289(2), 233-240 (2008).
89. Schlessinger J, Lemmon MA: SH2 and PTB domains in tyrosine kinase signaling. Sci. STKE 2003(191), RE12 (2003).
90. Scita G, Tenca P, Areces LB et al.: An effector region in Eps8 is responsible for the activation of the Rac-specific GEF activity of Sos-1 and for the proper localization of the Rac-based actin-polymerizing machine. J. Cell Biol. 154(5), 1031-1044 (2001).
91. Zhou D, Mooseker MS, Galan JE: Role of the S. typhimurium actin-binding protein SipA in bacterial internalization. Science 283(5410), 2092-2095 (1999).
92. Zhou D, Mooseker MS, Galan JE: An invasion-associated Salmonella protein modulates the actin-bundling activity of plastin. Proc. Natl Acad. Sci. USA 96(18), 10176-10181 (1999).
93. Mcghie EJ, Hayward RD, Koronakis V: Control of actin turnover by a Salmonella invasion protein. Mol. Cell. 13(4), 497-510 (2004).
94. Hayward RD, Koronakis V: Direct nucleation and bundling of actin by the SipC protein of invasive Salmonella. EMBO J. 18(18), 4926-4934 (1999).
95. Mcghie EJ, Hayward RD, Koronakis V: Cooperation between actin-binding proteins of invasive Salmonella: SipA potentiates SipC nucleation and bundling of actin. EMBO J. 20(9), 2131-2139 (2001).
96. Kueltzo LA, Osiecki J, Barker J et al.: Structure-function analysis of invasion plasmid antigen c (IpaC) from Shigella flexneri. J. Biol. Chem. 278(5), 2792-2798 (2003).
97. Jewett TJ, Fischer ER, Mead DJ, Hackstadt T: Chlamydial tarp is a bacterial nucleator of actin. Proc. Natl Acad. Sci. USA 103(42), 15599-15604 (2006).
98. Demali KA, Jue AL, Burridge K: IpaA targets p1 integrins and rho to promote actin cytoskeleton rearrangements necessary for Shigella entry. J. Biol. Chem. 281(51), 39534-39541 (2006).
99. Bourdet-Sicard R, Rudiger M, Jockusch BM, Gounon P, Sansonetti PJ, Nhieu GT: Binding of the Shigella protein IpaA to vinculin induces f-actin depolymerization. EMBO J. 18(21), 5853-5862 (1999).
100. Ramarao N, Le Clainche C, Izard T et al.: Capping of actin filaments by vinculin activated by the Shigella IpaA carboxyl-terminal domain. FEBSLett. 581(5), 853-857 (2007).
101. Izard T, Tran Van Nhieu G, Bois PRJ: Shigella applies molecular mimicry to subvert vinculin and invade host cells. J. Cell Biol. 175(3), 465-475 (2006).
102. Tran Van Nhieu G, Ben-Ze'ev A, Sansonetti PJ: Modulation of bacterial entry into epithelial cells by association between vinculin and the Shigella IpaA invasin. EMBO J. 16(10), 2717-2729 (1997).
103. Hower S, Wolf K, Fields K: Evidence that CT694 is a novel Chlamydia trachomatis T3S substrate capable of functioning during invasion or early-cycle development. Mol. Microbiol. 2(6), 1423-1437 (2009).
104. Benaud C, Gentil BJ, Assard N et al.: Ahnak interaction with the annexin 2/s100a10 complex regulates cell membrane cytoarchitecture. J. Cell Biol. 164(1), 133-144 (2004).
105. Niebuhr K, Jouihri N, Allaoui A, Gounon P, Sansonetti PJ, Parsot C: IpgD, a protein secreted by the type III secretion machinery of Shigella flexneri, is chaperoned by IpgE and implicated in entry focus formation. Mol. Microbiol. 38(1), 8-19 (2000).
106. Niebuhr K, Giuriato S, Pedron T et al.: Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S. flexneri effector IpgD reorganizes host cell morphology. EMBO J. 21(19), 5069-5078 (2002).
107. Balla T: Inositol-lipid binding motifs: signal integrators through protein-lipid and protein-protein interactions. J. Cell Sci. 118 (Pt 10), 2093-2104 (2005).
108. Terebiznik MR, Payrastre B, Finlay BB, Grinstein S: Alteration of epithelial structure and function associated with PtdIns(4,5)P2 degradation by a bacterial phosphatase. J. Gen. Physiol. 129(4), 267-283 (2007).
109. Terebiznik MR, Vieira OV, Marcus SL et al.: Elimination of host cell PtdIns(4,5)P(2) by bacterial SigD promotes membrane fission during invasion by Salmonella. Nat. Cell Biol. 4(10), 766-773 (2002).
110. Ly KT, Casanova JE: Abelson tyrosine kinase facilitates Salmonella enterica serovar typhimurium entry into epithelial cells. Infect. Immun. 77(1), 60-69 (2009).
111. Burton EA, Plattner R, Pendergast AM: Abl tyrosine kinases are required for infection by Shigella flexneri. EMBO J. 22(20), 5471-5479 (2003).
112. Steffen A, Rottner K, Ehinger J et al.: Sra-1 and Nap1 link rac to actin assembly driving lamellipodia formation. EMBO J. 23(4), 749-759 (2004).
113. Leng Y, Zhang J, Badour K et al.: Abelson-interactor-1 promotes WAVE2 membrane translocation and abelson-mediated tyrosine phosphorylation required for WAVE2 activation. Proc. Natl Acad. Sci. USA 102(4), 1098-1103 (2005).
114. Shi J, Scita G, Casanova JE: WAVE2 signaling mediates invasion of polarized epithelial cells by Salmonella typhimurium. J. Biol. Chem. 280(33), 29849-29855 (2005).
115. Abassi YA, Vuori K: Tyrosine 221 in Crk regulates adhesion-dependent membrane localization of Crk and Rac and activation of rac signaling. EMBO J. 21(17), 4571-4582 (2002).
116. Shi J, Casanova JE: Invasion of host cells by Salmonella typhimurium requires focal adhesion kinase and p130Cas. Mol. Biol. Cell 17(11), 4698-4708 (2006).
117. Unsworth KE, Way M, Mcniven M, Machesky L, Holden DW: Analysis of the mechanisms of Salmonella-induced actin assembly during invasion of host cells and intracellular replication. Cell Microbiol. 6(11), 1041-1055 (2004).
118. Mounier J, Popoff MR, Enninga J, Frame MC, Sansonetti PJ, Van Nhieu GT: The IpaC carboxyterminal effector domain mediates Src-dependent actin polymerization during Shigella invasion of epithelial cells. PLoS Pathog. 5(1), e1000271 (2009).
119. Bougneres L, Girardin SE, Weed SA et al.: Cortactin and Crk cooperate to trigger actin polymerization during Shigella invasion of epithelial cells. J. Cell Biol. 166(2), 225-235 (2004).
120. Dehio C, Prevost MC, Sansonetti PJ: Invasion of epithelial cells by Shigella flexneri induces tyrosine phosphorylation of cortactin by a pp60c-Src-mediated signalling pathway. EMBO J. 14(11), 2471-2482 (1995).
121. Boyle SN, Michaud GA, Schweitzer B, Predki PF, Koleske AJ: A critical role for cortactin phosphorylation by Abl-family kinases in PDGF-induced dorsal-wave formation. Curr. Biol. 17(5), 445-451 (2007).
122. Swanson KA, Crane DD, Caldwell HD: Chlamydia trachomatis species-specific induction of ezrin tyrosine phosphorylation functions in pathogen entry. Infect. Immun. 75(12), 5669-5677 (2007).
123. Kocher HM, Sandle J, Mirza TA, Li NF, Hart IR: Ezrin interacts with cortactin to form podosomal rosettes in pancreatic cancer cells. Gut 58(2), 271-284 (2009).
124. Amanchy R, Zhong J, Hong R et al.: Identification of c-Src tyrosine kinase substrates in platelet-derived growth factor receptor signaling. Mol. Oncol. 3(5-6), 439-450 (2009).
125. Kline T, Barry KC, Jackson SR, Felise HB, Nguyen HV, Miller SI: Tethered thiazolidinone dimers as inhibitors of the bacterial type III secretion system. Bioorg. Med. Chem. Lett. 19(5), 1340-1343 (2009).
126. Kline T, Felise HB, Barry KC, Jackson SR, Nguyen HV, Miller SI: Substituted 2-imino-5-arylidenethiazolidin-4-one inhibitors of bacterial type III secretion. J. Med. Chem. 51(22), 7065-7074 (2008).
127. Keyser P, Elofsson M, Rosell S, Wolf-Watz H: Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram-negative bacteria. J. Intern. Med. 264(1), 17-29 (2008).
128. Veenendaal AKJ, Sundin C, Blocker AJ: Small-molecule type III secretion system inhibitors block assembly of the Shigella type III secreton. J. Bacteriol. 191(2), 563-570 (2009).
129. Binet R, Maurelli AT: Transformation and isolation of allelic exchange mutants of Chlamydiapsittaci using recombinant DNA introduced by electroporation. Proc. Natl Acad. Sci. USA 106(1), 292-297 (2009).
130. Sisko JL, Spaeth K, Kumar Y, Valdivia RH: Multifunctional analysis of Chlamydia-specific genes in a yeast expression system. Mol. Microbiol. 60(1), 51-66 (2006).
131. Delevoye C, Nilges M, Dautry-Varsat A, Subtil A: Conservation of the biochemical properties of inca from Chlamydia trachomatis and Chlamydia caviae: oligomerization of IncA mediates interaction between facing membranes. J. Biol. Chem. 279(45), 46896-46906 (2004).
132. Cortes C, Rzomp KA, Tvinnereim A, Scidmore MA, Wizel B : Chlamydia pneumoniae inclusion membrane protein Cpn0585 interacts with multiple Rab GTPases. Infect. Immun. 75(12), 5586-5596 (2007).
133. Huang J, Lesser CF, Lory S: The essential role of the CopN protein in Chlamydia pneumoniae intracellular growth. Nature 456(7218), 112-115 (2008).
134. Hybiske K, Stephens RS: Mechanisms of Chlamydia trachomatis entry into nonphagocytic cells. Infect. Immun. 75(8), 3925-3934 (2007).